Biotoxtech Co Ltd (086040)

Currency in KRW
2,225
+25(+1.14%)
Closed·
Advertisement
086040 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,1502,280
52 wk Range
1,8964,115
Key Statistics
Bid/Ask
2,200.00 / 2,225.00
Prev. Close
2,225
Open
2,180
Day's Range
2,150-2,280
52 wk Range
1,896-4,115
Volume
11.71K
Average Volume (3m)
65.93K
1-Year Change
-25.8333%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
086040 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15/05/2026
EPS / Forecast
-121.46 / --
Revenue / Forecast
11.87B / --
EPS Revisions
Last 90 days

Compare 086040 to Peers and Sector

Metrics to compare
086040
Peers
Sector
Relationship
P/E Ratio
45.5x12.6x−0.4x
PEG Ratio
0.410.140.00
Price/Book
0.9x1.0x2.6x
Price / LTM Sales
0.7x2.4x3.0x
Upside (Analyst Target)
-68.6%49.7%
Fair Value Upside
Unlock30.5%7.3%Unlock

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity test, immunotoxicity test, safety pharmacology test, aquatic ecotoxicology test, histopathology/clinical pathology, and animal testing method. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
2.98M18.98%6.56B
Public Companies & Retail Investors
12.74M81.02%28.02B
Total
15.72M100.00%34.59B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Celltrion, Inc.10.38%1,631,1343,588,495
Keyfronbio Co., Ltd.8.60%1,352,6912,975,920

FAQ

What Is the Biotoxtech (KOSDAQ: 086040) Share Price Today?

The Biotoxtech stock price today is 2,225 KRW.

What Stock Exchange Does Biotoxtech (086040) Trade On?

Biotoxtech is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Biotoxtech?

The stock symbol (also called a 'ticker') for Biotoxtech is "086040."

What Is the Current Biotoxtech Market Capitalisation?

As of today, Biotoxtech (KOSDAQ: 086040) market cap is 34.98B KRW.

What Is Biotoxtech's (086040) Earnings Per Share (TTM)?

The Biotoxtech EPS is currently 49 (Trailing Twelve Months).

Is 086040 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Biotoxtech moving averages and other technical indicators, the daily buy/sell signal for 086040 stock is Neutral.

How Many Times Has Biotoxtech Stock Split?

Biotoxtech has split 1 times. (See the 086040 stock split history page for full effective split date and price information.)

How Many Employees Does Biotoxtech Have?

Biotoxtech has 188 employees, based on their latest Companies House report.

What is the current trading status of Biotoxtech (KOSDAQ: 086040)?

As of 08/07/2026, Biotoxtech (086040) is trading at a share price of 2,225 KRW, with a previous close of 2,225 KRW. The stock has fluctuated within a day range of 2,150 KRW to 2,280 KRW, while its 52-week range spans from 1,896 KRW to 4,115 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.